Skip to main content
PMC home page
Gut logoLink to Gut
. 1998 Jul;43(Suppl 1):S14–S20. doi: 10.1136/gut.43.2008.s14

Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?

J Lee, C O'Morain
PMCID: PMC1766593  PMID: 9764033

Full Text

The Full Text of this article is available as a PDF (110.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnett J. L., Behler E. M., Appelman H. D., Elta G. H. Campylobacter pylori is not associated with gastroparesis. Dig Dis Sci. 1989 Nov;34(11):1677–1680. doi: 10.1007/BF01540043. [DOI] [PubMed] [Google Scholar]
  2. Blot W. J., Devesa S. S., Fraumeni J. F., Jr Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993 Sep 15;270(11):1320–1320. [PubMed] [Google Scholar]
  3. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F., Jr Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991 Mar 13;265(10):1287–1289. [PubMed] [Google Scholar]
  4. Borkent M. V., Beker J. A. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine. Gut. 1988 Mar;29(3):385–389. doi: 10.1136/gut.29.3.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cadiot G., Bruhat A., Rigaud D., Coste T., Vuagnat A., Benyedder Y., Vallot T., Le Guludec D., Mignon M. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut. 1997 Feb;40(2):167–174. doi: 10.1136/gut.40.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cameron A. J., Ott B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985 Oct 3;313(14):857–859. doi: 10.1056/NEJM198510033131404. [DOI] [PubMed] [Google Scholar]
  7. Cheng E. H., Bermanski P., Silversmith M., Valenstein P., Kawanishi H. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Arch Intern Med. 1989 Jun;149(6):1373–1375. [PubMed] [Google Scholar]
  8. Collen M. J., Johnson D. A., Sheridan M. J. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci. 1994 Feb;39(2):410–417. doi: 10.1007/BF02090216. [DOI] [PubMed] [Google Scholar]
  9. Collen M. J., Lewis J. H., Benjamin S. B. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology. 1990 Mar;98(3):654–661. doi: 10.1016/0016-5085(90)90285-9. [DOI] [PubMed] [Google Scholar]
  10. Csendes A., Smok G., Cerda G., Burdiles P., Mazza D., Csendes P. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus. 1997 Jan;10(1):38–42. doi: 10.1093/dote/10.1.38. [DOI] [PubMed] [Google Scholar]
  11. Cunningham K. M., Horowitz M., Riddell P. S., Maddern G. J., Myers J. C., Holloway R. H., Wishart J. M., Jamieson G. G. Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease. Gut. 1991 Dec;32(12):1436–1440. doi: 10.1136/gut.32.12.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dent J., Holloway R. H., Toouli J., Dodds W. J. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut. 1988 Aug;29(8):1020–1028. doi: 10.1136/gut.29.8.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eissele R., Brunner G., Simon B., Solcia E., Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology. 1997 Mar;112(3):707–717. doi: 10.1053/gast.1997.v112.pm9041231. [DOI] [PubMed] [Google Scholar]
  14. El-Omar E. M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., Williams C., Ardill J. E., McColl K. E. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997 Jul;113(1):15–24. doi: 10.1016/s0016-5085(97)70075-1. [DOI] [PubMed] [Google Scholar]
  15. Fink S. M., Barwick K. W., DeLuca V., Sanders F. J., Kandathil M., McCallum R. W. The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying. J Clin Gastroenterol. 1984 Aug;6(4):301–309. [PubMed] [Google Scholar]
  16. Francoual S., Lamy P., Le Quintrec Y., Luboinski J., Petit J. C. Helicobacter pylori: has it a part in the lesion of the gastroesophageal reflux? J Infect Dis. 1990 Dec;162(6):1414–1415. doi: 10.1093/infdis/162.6.1414. [DOI] [PubMed] [Google Scholar]
  17. Graham D. Y., Go M. F., Lew G. M., Genta R. M., Rehfeld J. F. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol. 1993 Aug;28(8):690–694. doi: 10.3109/00365529309098274. [DOI] [PubMed] [Google Scholar]
  18. Götz J. M., Veenendaal R. A., Biemond I., Muller E. S., Veselic M., Lamers C. B. Serum gastrin and mucosal somatostatin in Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 1995 Nov;30(11):1064–1068. doi: 10.3109/00365529509101608. [DOI] [PubMed] [Google Scholar]
  19. Hameeteman W., Tytgat G. N., Houthoff H. J., van den Tweel J. G. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989 May;96(5 Pt 1):1249–1256. doi: 10.1016/s0016-5085(89)80011-3. [DOI] [PubMed] [Google Scholar]
  20. Harris A. W., Gummett P. A., Misiewicz J. J., Baron J. H. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut. 1996 May;38(5):663–667. doi: 10.1136/gut.38.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Haruma K., Sumii K., Okamoto S., Yoshihara M., Sumii M., Kajiyama G., Wagner S. Helicobacter pylori infection is associated with low antral somatostatin content in young adults. Implications for the pathogenesis of hypergastrinemia. Scand J Gastroenterol. 1995 Jun;30(6):550–553. doi: 10.3109/00365529509089788. [DOI] [PubMed] [Google Scholar]
  22. Hatlebakk J. G., Berstad A. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis. Scand J Gastroenterol. 1996 Oct;31(10):954–958. doi: 10.3109/00365529609003113. [DOI] [PubMed] [Google Scholar]
  23. Hirschowitz B. I. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology. 1991 Nov;101(5):1149–1158. doi: 10.1016/0016-5085(91)90062-p. [DOI] [PubMed] [Google Scholar]
  24. Isolauri J., Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med. 1995 Feb;27(1):67–70. doi: 10.3109/07853899509031939. [DOI] [PubMed] [Google Scholar]
  25. Isolauri J., Luostarinen M., Isolauri E., Reinikainen P., Viljakka M., Keyriläinen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol. 1997 Jan;92(1):37–41. [PubMed] [Google Scholar]
  26. Jankowski J., Murphy S., Coghill G., Grant A., Wormsley K. G., Sanders D. S., Kerr M., Hopwood D. Epidermal growth factor receptors in the oesophagus. Gut. 1992 Apr;33(4):439–443. doi: 10.1136/gut.33.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kaneko H., Nakada K., Mitsuma T., Uchida K., Furusawa A., Maeda Y., Morise K. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci. 1992 Mar;37(3):409–416. doi: 10.1007/BF01307736. [DOI] [PubMed] [Google Scholar]
  28. Kuipers E. J., Uyterlinde A. M., Peña A. S., Hazenberg H. J., Bloemena E., Lindeman J., Klinkenberg-Knol E. C., Meuwissen S. G. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995 Sep;90(9):1401–1406. [PubMed] [Google Scholar]
  29. Labenz J., Blum A. L., Bayerdörffer E., Meining A., Stolte M., Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997 May;112(5):1442–1447. doi: 10.1016/s0016-5085(97)70024-6. [DOI] [PubMed] [Google Scholar]
  30. Labenz J., Tillenburg B., Peitz U., Idström J. P., Verdú E. F., Stolte M., Börsch G., Blum A. L. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology. 1996 Mar;110(3):725–732. doi: 10.1053/gast.1996.v110.pm8608881. [DOI] [PubMed] [Google Scholar]
  31. Lee J., O'Morain C. Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol. 1997 May;9(5):527–531. doi: 10.1097/00042737-199705000-00021. [DOI] [PubMed] [Google Scholar]
  32. Levi S., Beardshall K., Haddad G., Playford R., Ghosh P., Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989 May 27;1(8648):1167–1168. doi: 10.1016/s0140-6736(89)92752-9. [DOI] [PubMed] [Google Scholar]
  33. Liston R., Pitt M. A., Banerjee A. K. Reflux oesophagitis and Helicobacter pylori infection in elderly patients. Postgrad Med J. 1996 Apr;72(846):221–223. doi: 10.1136/pgmj.72.846.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Logan R. P., Walker M. M., Misiewicz J. J., Gummett P. A., Karim Q. N., Baron J. H. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 1995 Jan;36(1):12–16. doi: 10.1136/gut.36.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Malfertheiner P., Mégraud F., O'Morain C., Bell D., Bianchi Porro G., Deltenre M., Forman D., Gasbarrini G., Jaup B., Misiewicz J. J. Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997 Jan;9(1):1–2. doi: 10.1097/00042737-199701000-00002. [DOI] [PubMed] [Google Scholar]
  36. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  37. McCallum R. W., Berkowitz D. M., Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology. 1981 Feb;80(2):285–291. [PubMed] [Google Scholar]
  38. McColl K. E., Fullarton G. M., Chittajalu R., el Nujumi A. M., MacDonald A. M., Dahill S. W., Hilditch T. E. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol. 1991 Mar;26(3):339–346. doi: 10.3109/00365529109025052. [DOI] [PubMed] [Google Scholar]
  39. McDougall N. I., Johnston B. T., Kee F., Collins J. S., McFarland R. J., Love A. H. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 1996 Apr;38(4):481–486. doi: 10.1136/gut.38.4.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Miller L. S., Vinayek R., Frucht H., Gardner J. D., Jensen R. T., Maton P. N. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology. 1990 Feb;98(2):341–346. doi: 10.1016/0016-5085(90)90823-j. [DOI] [PubMed] [Google Scholar]
  41. Minocha A., Mokshagundam S., Gallo S. H., Rahal P. S. Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol. 1994 Oct;89(10):1797–1800. [PubMed] [Google Scholar]
  42. Mittal R. K., Holloway R. H., Penagini R., Blackshaw L. A., Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995 Aug;109(2):601–610. doi: 10.1016/0016-5085(95)90351-8. [DOI] [PubMed] [Google Scholar]
  43. Moss S. F., Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut. 1993 Jul;34(7):888–892. doi: 10.1136/gut.34.7.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Moss S. F., Legon S., Bishop A. E., Polak J. M., Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet. 1992 Oct 17;340(8825):930–932. doi: 10.1016/0140-6736(92)92816-x. [DOI] [PubMed] [Google Scholar]
  45. Mousses S., McAuley L., Bell R. S., Kandel R., Andrulis I. L. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod Pathol. 1996 Jan;9(1):1–6. [PubMed] [Google Scholar]
  46. Nebel O. T., Fornes M. F., Castell D. O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976 Nov;21(11):953–956. doi: 10.1007/BF01071906. [DOI] [PubMed] [Google Scholar]
  47. Newton M., Bryan R., Burnham W. R., Kamm M. A. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut. 1997 Jan;40(1):9–13. doi: 10.1136/gut.40.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. O'Connor H. J., Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease--a prospective study. Ir J Med Sci. 1994 Aug;163(8):369–373. doi: 10.1007/BF02942830. [DOI] [PubMed] [Google Scholar]
  49. Oderda G., Vaira D., Holton J., Ainley C., Altare F., Ansaldi N. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet. 1989 Apr 1;1(8640):690–692. doi: 10.1016/s0140-6736(89)92206-x. [DOI] [PubMed] [Google Scholar]
  50. Odum L., Petersen H. D., Andersen I. B., Hansen B. F., Rehfeld J. F. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut. 1994 May;35(5):615–618. doi: 10.1136/gut.35.5.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Orlando R. C., Bryson J. C., Powell D. W. Mechanisms of H+ injury in rabbit esophageal epithelium. Am J Physiol. 1984 Jun;246(6 Pt 1):G718–G724. doi: 10.1152/ajpgi.1984.246.6.G718. [DOI] [PubMed] [Google Scholar]
  52. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  53. Rees C. J., Hudson M., Record C. O. Therapeutic modalities in portal hypertension. Eur J Gastroenterol Hepatol. 1997 Jan;9(1):9–11. doi: 10.1097/00042737-199701000-00005. [DOI] [PubMed] [Google Scholar]
  54. Richter J. E. Delayed gastric emptying in reflux patients: to be or not to be? Am J Gastroenterol. 1997 Jul;92(7):1077–1078. [PubMed] [Google Scholar]
  55. Safaie-Shirazi S., DenBesten L., Zike W. L. Effect of bile salts on the ionic permeability of the esophageal mucosa and their role in the production of esophagitis. Gastroenterology. 1975 Apr;68(4 Pt 1):728–733. [PubMed] [Google Scholar]
  56. Saksena S., Elias E. Transjugular intrahepatic portosystemic shunting (TIPS): a shunt is a shunt is a shunt! Eur J Gastroenterol Hepatol. 1997 Jan;9(1):3–5. doi: 10.1097/00042737-199701000-00003. [DOI] [PubMed] [Google Scholar]
  57. Scott A. M., Kellow J. E., Shuter B., Cowan H., Corbett A. M., Riley J. W., Lunzer M. R., Eckstein R. P., Höschl R., Lam S. K. Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Lack of influence of symptom subgroups and H. pylori-associated gastritis. Dig Dis Sci. 1993 Dec;38(12):2247–2254. doi: 10.1007/BF01299904. [DOI] [PubMed] [Google Scholar]
  58. Shallcross T. M., Wyatt J. I., Rathbone B. J., Heatley R. V. Non-steroidal anti-inflammatory drugs, hiatus hernia, and Helicobacter pylori, in patients with oesophageal ulceration. Br J Rheumatol. 1990 Aug;29(4):288–290. doi: 10.1093/rheumatology/29.4.288. [DOI] [PubMed] [Google Scholar]
  59. Smith J. T., Pounder R. E., Nwokolo C. U., Lanzon-Miller S., Evans D. G., Graham D. Y., Evans D. J., Jr Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut. 1990 May;31(5):522–525. doi: 10.1136/gut.31.5.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Spechler S. J., Goyal R. K. Barrett's esophagus. N Engl J Med. 1986 Aug 7;315(6):362–371. doi: 10.1056/NEJM198608073150605. [DOI] [PubMed] [Google Scholar]
  61. Stanciu C., Bennett J. R. Oesophageal acid clearing: one factor in the production of reflux oesophagitis. Gut. 1974 Nov;15(11):852–857. doi: 10.1136/gut.15.11.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Stewart R. J., Boston V. E., Dodge J. A., Emmerson A. M. Campylobacter pylori and reflux oesophagitis. Acta Paediatr Scand. 1990 Jan;79(1):107–107. doi: 10.1111/j.1651-2227.1990.tb11339.x. [DOI] [PubMed] [Google Scholar]
  63. Sumii M., Sumii K., Tari A., Kawaguchi H., Yamamoto G., Takehara Y., Fukino Y., Kamiyasu T., Hamada M., Tsuda T. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenterol. 1994 Sep;89(9):1515–1519. [PubMed] [Google Scholar]
  64. Tee W., Lambert J. R., Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol. 1995 May;33(5):1203–1205. doi: 10.1128/jcm.33.5.1203-1205.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Thompson W. G., Heaton K. W. Heartburn and globus in apparently healthy people. Can Med Assoc J. 1982 Jan 1;126(1):46–48. [PMC free article] [PubMed] [Google Scholar]
  66. Tytgat G. N., Janssens J., Reynolds J. C., Wienbeck M. Update on the pathophysiology and management of gastro-oesophageal reflux disease: the role of prokinetic therapy. Eur J Gastroenterol Hepatol. 1996 Jun;8(6):603–611. doi: 10.1097/00042737-199606000-00020. [DOI] [PubMed] [Google Scholar]
  67. Verdú E. F., Armstrong D., Fraser R., Viani F., Idström J. P., Cederberg C., Blum A. L. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut. 1995 Apr;36(4):539–543. doi: 10.1136/gut.36.4.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Verdú E. F., Armstrong D., Idström J. P., Labenz J., Stolte M., Dorta G., Börsch G., Blum A. L. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut. 1995 Dec;37(6):743–748. doi: 10.1136/gut.37.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Vicari J., Falk G. W., Richter J. E. Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol. 1997 Jul;92(7):1097–1102. [PubMed] [Google Scholar]
  70. Werdmuller B. F., Loffeld R. J. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci. 1997 Jan;42(1):103–105. doi: 10.1023/a:1018841222856. [DOI] [PubMed] [Google Scholar]
  71. el-Omar E. M., Penman I. D., Ardill J. E., Chittajallu R. S., Howie C., McColl K. E. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995 Sep;109(3):681–691. doi: 10.1016/0016-5085(95)90374-7. [DOI] [PubMed] [Google Scholar]
  72. el-Omar E., Penman I., Dorrian C. A., Ardill J. E., McColl K. E. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut. 1993 Aug;34(8):1060–1065. doi: 10.1136/gut.34.8.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES